473
Views
21
CrossRef citations to date
0
Altmetric
Reviews

Medical treatment of small cell lung cancer: state of the art and new development

, MD, , MD, , MD, , MD, , MD, , MD, , MD & , MD show all
Pages 2019-2031 | Published online: 01 Aug 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Li Yu, Kefeng Li, Zhaoguo Xu, Guoyuan Cui & Xiaoye Zhang. (2018) Integrated omics and gene expression analysis identifies the loss of metabolite–metabolite correlations in small cell lung cancer. OncoTargets and Therapy 11, pages 3919-3929.
Read now
Helai P. Mohammad & Ryan G. Kruger. (2016) Antitumor activity of LSD1 inhibitors in lung cancer. Molecular & Cellular Oncology 3:2.
Read now
Huan-Huan Wang, Nicholas G Zaorsky, Mao-Bin Meng, Zhi-Qiang Wu, Xian-Liang Zeng, Bo Jiang, Chao Jiang, Lu-Jun Zhao, Zhi-Yong Yuan & Ping Wang. (2015) Multimodality therapy is recommended for limited-stage combined small cell esophageal carcinoma. OncoTargets and Therapy 8, pages 437-444.
Read now

Articles from other publishers (18)

Qunxia Wang & Li‐Ming Tan. (2023) Advances in the role of circulating tumor cell heterogeneity in metastatic small cell lung cancer. Cancer Innovation.
Crossref
Sebastian Klein, Annalena Schulte, Christoph Arolt, Yuri Tolkach, Hans Christian Reinhardt, Reinhard Buettner & Alexander Quaas. (2023) Intratumoral Abundance of M2-Macrophages is Associated With Unfavorable Prognosis and Markers of T-Cell Exhaustion in Small Cell Lung Cancer Patients. Modern Pathology 36:10, pages 100272.
Crossref
Annikka WeissferdtAnnikka Weissferdt. 2020. Diagnostic Thoracic Pathology. Diagnostic Thoracic Pathology 401 434 .
Lum & Alamgeer. (2019) Technological and Therapeutic Advances in Advanced Small Cell Lung Cancer. Cancers 11:10, pages 1570.
Crossref
Nicola Fazio & Manila Rubino. 2018. Neuroendocrine Tumors in Real Life. Neuroendocrine Tumors in Real Life 335 342 .
Shadia I. Jalal, Nasser Hanna, Robin Zon, Gregory A. Masters, Hossein Borghaei, Karuna Koneru, Sunil Badve, Nagendra Prasad, Neeta Somaiah, Jingwei Wu, Zhangsheng Yu & Lawrence Einhorn. (2017) Phase I Study of Amrubicin and Cyclophosphamide in Patients With Advanced Solid Organ Malignancies. American Journal of Clinical Oncology 40:4, pages 329-335.
Crossref
Xuemei Yang, Chunlan Tang, Hu Luo, Haijing Wang & Xiangdong Zhou. (2017) Shp2 confers cisplatin resistance in small cell lung cancer via an AKT-mediated increase in CA916798. Oncotarget 8:14, pages 23664-23674.
Crossref
Takanobu Jotatsu, Shigehiro Yagishita, Ken Tajima, Fumiyuki Takahashi, Kaoru Mogushi, Moulid Hidayat, Aditya Wirawan, Ryo Ko, Ryota Kanemaru, Naoko Shimada, Keiko Mitani, Tsuyoshi Saito, Kazuya Takamochi, Kenji Suzuki, Shinji Kohsaka, Shinya Kojima, Hiroshi Mukae, Kazuhiro Yatera & Kazuhisa Takahashi. (2017) LSD1/KDM1 isoform LSD1+8a contributes to neural differentiation in small cell lung cancer. Biochemistry and Biophysics Reports 9, pages 86-94.
Crossref
Gemma Leon, Lauren MacDonagh, Stephen P. Finn, Sinead Cuffe & Martin P. Barr. (2016) Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways. Pharmacology & Therapeutics 158, pages 71-90.
Crossref
Erkan Topkan, Berna Akkus Yildirim & Ugur Selek. 2016. Principles and Practice of Radiotherapy Techniques in Thoracic Malignancies. Principles and Practice of Radiotherapy Techniques in Thoracic Malignancies 163 198 .
Zhen Liang, Nan Yang, Yao Jiang, Chunying Hou, Ji Zheng, Jiaojiao Shi, Rui Zhang, Dongmei Li, Yanyong Liu & Pingping Zuo. (2015) Targeting docetaxel-PLA nanoparticles simultaneously inhibit tumor growth and liver metastases of small cell lung cancer. International Journal of Pharmaceutics 494:1, pages 337-345.
Crossref
Gerhard Hamilton & Barbara Rath. (2015) Smoking, inflammation and small cell lung cancer: recent developments. Wiener Medizinische Wochenschrift 165:19-20, pages 379-386.
Crossref
Ekaterina A. Semenova, Remco Nagel & Anton Berns. (2015) Origins, genetic landscape, and emerging therapies of small cell lung cancer. Genes & Development 29:14, pages 1447-1462.
Crossref
Helai P. Mohammad, Kimberly N. Smitheman, Chandrashekhar D. Kamat, David Soong, Kelly E. Federowicz, Glenn S. Van Aller, Jess L. Schneck, Jeffrey D. Carson, Yan Liu, Michael Butticello, William G. Bonnette, Shelby A. Gorman, Yan Degenhardt, Yuchen Bai, Michael T. McCabe, Melissa B. Pappalardi, Jiri Kasparec, Xinrong Tian, Kenneth C. McNulty, Meagan Rouse, Patrick McDevitt, Thau Ho, Michelle Crouthamel, Timothy K. Hart, Nestor O. Concha, Charles F. McHugh, William H. Miller, Dashyant Dhanak, Peter J. Tummino, Christopher L. Carpenter, Neil W. Johnson, Christine L. Hann & Ryan G. Kruger. (2015) A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC. Cancer Cell 28:1, pages 57-69.
Crossref
Núria Buil-Bruna, Tarjinder Sahota, José-María López-Picazo, Marta Moreno-Jiménez, Salvador Martín-Algarra, Benjamin Ribba & Iñaki F. Trocóniz. (2015) Early Prediction of Disease Progression in Small Cell Lung Cancer: Toward Model-Based Personalized Medicine in Oncology. Cancer Research 75:12, pages 2416-2425.
Crossref
Tracy L. Leong, Kieren D. Marini, Fernando J. Rossello, Samantha N. Jayasekara, Prudence A. Russell, Zdenka Prodanovic, Beena Kumar, Vinod Ganju, Muhammad Alamgeer, Louis B. Irving, Daniel P. Steinfort, Craig D. Peacock, Jason E. Cain, Anette Szczepny & D. Neil Watkins. (2014) Genomic Characterisation of Small Cell Lung Cancer Patient-Derived Xenografts Generated from Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Specimens. PLoS ONE 9:9, pages e106862.
Crossref
Giulio Rossi, Alessandra Bisagni & Alberto Cavazza. (2014) High-grade neuroendocrine carcinoma. Current Opinion in Pulmonary Medicine 20:4, pages 332-339.
Crossref
Laurentiu M. Pop, Stephen Barman, Chunli Shao, Jonathan C. Poe, Guglielmo M. Venturi, John M. Shelton, Iliodora V. Pop, David E. Gerber, Luc Girard, Xiao-yun Liu, Carmen Behrens, Jaime Rodriguez-Canales, Hui Liu, Ignacio I. Wistuba, James A. Richardson, John D. Minna, Thomas F. Tedder & Ellen S. Vitetta. (2014) A Reevaluation of CD22 Expression in Human Lung Cancer. Cancer Research 74:1, pages 263-271.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.